Dysregulation of FAAH and MAGL activity can lead to altered endocannabinoid signaling, contributing to conditions like chronic pain, obesity, and metabolic disorders (De Filippo et al., 2023; Cravatt et al., 2001). This evidence concerns the gene MGLL and obesity due to melanocortin 4 receptor deficiency.